Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
William Blair Starts Aratana Therapeutics (PETX) at Outperform
July 23, 2013 7:27 AM EDTWilliam Blair initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with an Outperform.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
JMP Securities Starts Aratana Therapeutics (PETX) at Market Outperform
July 22, 2013 9:01 AM EDTJMP Securities initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Market Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
Craig-Hallum Starts Aratana Therapeutics (PETX) at Buy
July 22, 2013 9:00 AM EDTCraig-Hallum initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
Stifel Nicolaus Starts Aratana Therapeutics (PETX) at Buy
July 22, 2013 8:33 AM EDTStifel Nicolaus initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $13.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
